ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1919

Regulatory T Cells in IgG4-Related Disease Patients Presenting with Sclerosing Sialadenitis and Dacryoadenitis

Winnie K. Pang1, Ya Liu2, Julie Wang2, Song Guo Zheng2, Kiran Qidwai3, Russell K. Brynes3 and Francisco P. Quismorio Jr.1, 1Rheumatology, University of Southern California Keck School of Medicine, Los Angeles, CA, 2Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, 3Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: T cells and immunoglobulin (IG)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: IgG4-Related Disease (IgG4-RD) is characterized by inflammation and fibrosis of various organ systems. Its diverse clinical presentations include autoimmune pancreatitis, retroperitoneal fibrosis, sialadenitis, and dacryoadenitis. The etiology and pathogenesis are not well understood; however, the role of regulatory T cells (Treg) has been suggested. We evaluated the phenotype and function of Tregs in IgG4-RD patients with lacrimal and salivary gland involvement.

Methods: Three untreated IgG4-RD patients with chronic lacrimal and salivary gland enlargement underwent clinical evaluation at the Los Angeles County Medical Center Rheumatology clinic. Peripheral blood mononuclear cells were obtained from healthy controls and the untreated IgG4-RD patients. Treg subsets were identified with a combination of monoclonal antibodies (anti-CD4, -CD25, -CD45RA, -Foxp3, -CCR7) conjugated to different fluorochromes. Intracellular cytokine production (IL-2, IL-4, IL-5, IL-17A, IFN-g) was assessed in T cells by flow cytometry after PMA/Ionomycin stimulation in vitro. Statistical analysis was performed using Mann-Whitney or Wilcoxon tests.

Results: The patients, initially referred to rheumatology for Sjogren’s Syndrome, had clinical and histopathologic features consistent with IgG4-RD. Patient 1 was a 50-year-old Caucasian female with submandibular and lacrimal gland swelling for 3 years. She also had an enlarged right submandibular gland excised in 1989. Patient 2 was a 60-year-old African American female with bilateral parotid and lacrimal gland swelling since 2007. Patient 3 was a 33-year-old Filipino male with a history of hemimandibulectomy for ameloblastoma in 1989 who presented with painless enlargement of the lacrimal and parotid glands for 18 months. All patients underwent PET-CT scan, which showed diffuse lymphadenopathy and metabolically active, enlarged lacrimal and salivary glands. Excisional biopsies were performed. Histopathologic evaluation excluded lymphoma but revealed diffuse fibrosis, lymphocytic infiltration, and elevated IgG4/IgG plasma cell staining ratio (>50%) consistent with the diagnosis of IgG4-RD. Serum IgG4 levels were elevated in two patients.

Compared to healthy controls, the frequency of Treg (CD4+CD25+FOXP3+) cells was remarkably decreased in IgG4-RD patients, whereas naïve Treg cells (population with naïve phenotype, CCR7+CD45RA+) were increased.  IgG4-RD patients were also characterized by increased circulating Th2 (including CD4+IL-4+, CD4+IL-5+) cells compared to healthy controls, while Th1 (CD4+IFN-g) and Th17 (CD4+IL17+) cells did not differ significantly.

Conclusion: IgG4-related sclerosing dacryoadenitis and sialadenitis may mimic Sjogren’s Syndrome, prompting referral to rheumatologists. Histopathologic evaluation is essential for diagnosis. Untreated IgG4-RD patients were found to have a higher percentage of Th2 and a lower percentage of Treg, suggesting that correcting the balance of Treg/Th2 cells may be a potential therapeutic approach.


Disclosure:

W. K. Pang,
None;

Y. Liu,
None;

J. Wang,
None;

S. G. Zheng,
None;

K. Qidwai,
None;

R. K. Brynes,
None;

F. P. Quismorio Jr.,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulatory-t-cells-in-igg4-related-disease-patients-presenting-with-sclerosing-sialadenitis-and-dacryoadenitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology